AJHO | Gotoper.com

Archive

Oncology Briefings™: Cases and Considerations in the Treatment of Hepatocellular Carcinoma

36th Annual Miami Breast Cancer Conference®

16th Annual Winter Lung Cancer Conference™

23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

35th Annual Miami Breast Cancer Conference®

22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma®

2nd Annual International Congress on Oncology Pathology™

19th Annual International Lung Cancer Congress®

New York GU™: 11th Annual Interdisciplinary Prostate Cancer Congress® and other Genitourinary Malignancies

2nd Annual School of Nursing Oncology™

36th Annual CFS®: Innovative Cancer Therapy for Tomorrow

2nd Annual New York Cardio-Endo-Renal Collaborative (NY CERC)

December 2017

November 2017

October 2017

September 2017

August 2017

July 2017

June 2017

May 2017

April 2017

March 2017

February 2017

January 2017

December 2016

November 2016

October 2016

September 2016

August 2016

July 2016

June 2016

May 2016

April 2016

March 2016

February 2016

January 2016

December 2015

November 2015

October 2015

September 2015

August 2015

July 2015

June 2015

May 2015

April 2015

March 2015

February 2015

January 2015

December 2014

November 2014

September 2014

August 2014

Issues List

Oncology Briefings™: Cases and Considerations in the Treatment of Hepatocellular Carcinoma

36th Annual Miami Breast Cancer Conference®

16th Annual Winter Lung Cancer Conference™

23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

SUN	MON	TUES	WED	THURS	FRI	SAT
			1 Beyond PD-1 Blockade: Novel Checkpoint Inhibitors Expires on Dec 01, 2021 CME 0.5 2nd Annual Virtual Tumor Board®: Navigating Novel Therapeutic Approaches for the Management of SCLC Across Lines of Care (7:00 PM - 8:30 PM EDT) December 1, 2021 Live Webcast CME 1.5 Oncology Best Practices™: Strategic Algorithms for Challenging Cases in Relapsed/Refractory Multiple Myeloma December 1, 2021 - December 1, 2022 CME 1.0 NSCLC Tumor Board: Multimodal Approaches to Optimize Immune Checkpoint Inhibition Strategies in Curative Settings (6:00 PM to 8:00 PM MT) December 1, 2021 Fairmont Scottsdale Princess CME 2.0	2 Virtual Hot Seat™: Experts Face Key Questions to Maximize the Use of PI3K Inhibitors Across Hematologic Malignancies (7:00 PM to 8:30 PM ET) December 2, 2021 Live Webcast CME 1.5 Sickle Cell Disease: Improving the Quality and Continuum of Acute and Ambulatory Patient Care December 2, 2021 Live Webcast CME 1.5	3	4 Improving Outcomes in MDS and MPN: Tailoring Treatment Based on Patient- and Disease-Specific Factors Expires on Dec 04, 2021 CME 2.5
5	6	7 Optimizing Management of Iron Overload: Strategies to Improve Identification and Treatment (7:00 pm - 8:30 pm EST) December 7, 2021 Live Webcast CME 1.5	8 Cancer Summaries and Commentaries™: Report from Chicago on Advances in Genitourinary Cancers Expires on Dec 08, 2021 CME 1.0 Medical Crossfire®: Navigating the Evolving Treatment Landscape for HR-Positive Breast Cancer December 8, 2021 San Antonio, TX CME 2.0	9 Medical Crossfire®: Sequencing of Disease-Modifying Therapies—Optimizing Outcomes in Patients With Multiple Sclerosis December 9, 2021 Live Webcast CME 1.0	10 Improving Outcomes and Quality of Life in Beta-Thalassemia: Patient Perspectives and Expert Recommendations (3:00 pm - 5:00 pm EST) December 10, 2021 Atlanta, GA CME 2.0 Adopting MRD Assessment for Hematologic Malignancies in Real-World Settings: Technique, Role, and Utilization to Improve Patient Outcomes (3:00 pm - 6:00 pm EST) December 10, 2021 Atlanta, GA CME 3.0 How We Do It™: Leveraging Novel Therapies and Patient Data to Inform Key Decisions in GvHD (7:00 pm - 10:00 pm EST) December 10, 2021 Atlanta, GA CME 3.0 Aligning the Evidence with the Patient to Individualize Treatment Considerations Along the CML Care Continuum (3:00 pm - 5:30 pm EST) December 10, 2021 Live, Virtual Satellite Symposium CME 2.5 Cases and Conversations™: Modifying the Course of Sickle Cell Disease with Modern Interventions (11:00 am - 1:30 pm EST) December 10, 2021 Atlanta, GA CME 2.5 Healthcare Team Collaborative: Optimizing Treatment and Prevention of VTE in Patients with Hematologic Malignancies (7:00 pm - 9:00 pm EST) December 10, 2021 Live Webcast CME 2.0 New Horizons in Hemophilia: Preparing for the Advent of Gene Therapy (7:00 pm - 9:30 pm EST) December 10, 2021 Atlanta, GA CME 2.5 Elucidating Novel BTKi Strategies in CLL/SLL and MCL: A Virtual Exploration to Bring Therapeutic Rationales and Evidence Into Perspective (11:00 am - 2:00 pm EST) December 10, 2021 Atlanta, GA CME 3.0 Leveraging Clinical Data to Inform Treatment Decisions for Patients with MDS: An Expert Case-Based Discussion (7:00 pm - 9:30 pm EST) December 10, 2021 Atlanta, GA CME 2.5 Cold Agglutinin Disease: Shifting the Treatment Paradigm through Improved Understanding of the Complement System (3:00 pm - 5:30 pm EST) December 10, 2021 Atlanta, GA CME 2.5 New Targets, New Combinations, New Treatment Goals: Assessing Therapeutic Options to Personalize Care in Multiple Myeloma (3:00 pm - 5:00 pm EST) December 10, 2021 Atlanta, GA CME 2.0 Optometry Times® EyeCon 2021 December 10, 2021 - December 11, 2021 Live Webcast Ophthalmology Times® EyeCon 2021 December 10, 2021 - December 11, 2021 Live Webcast CME 11.5 Bridging Clinical Gaps in B-cell Lymphomas: Linking Novel Mechanisms to Advance New Treatment Strategies (7:00 pm - 10:00 pm EST) December 10, 2021 Live, Virtual Satellite Symposium CME 3.0 Diagnosis and Treatment of MF and PV: Where Are We and Where Are We Going? (11:00 am - 2:00 pm EST) December 10, 2021 Atlanta, GA CME 3.0 Practice Changing Evidence to Personalize Immune Thrombocytopenia Care: How the Experts Handle Cases in Today’s Environment (3:00 pm - 5:00 pm EST) December 10, 2021 Live, Virtual Satellite Symposium CME 2.0	11 Understanding the Continuum of Care in SMA: The Importance of Early Diagnosis, Optimal Treatment, and Transitioning from Pediatric to Adult Care Teams Expires on Dec 11, 2021 CME 1.25 6th Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing Application December 11, 2021 New York, NY CME 5.25
12 PER Postgame: Breaking Down the Latest Data and Updates in Anemia of Chronic Kidney Disease — Fall 2021 Nephrology Meeting Takeaways December 12, 2021 Live Webcast CME 1.25	13 School of Breast Oncology® Live Video Webcast: Clinical Updates From San Antonio December 13, 2021 Live Webcast CME 2.0	14 Medical Crossfire: How Can We Refine Our Approaches to Better Personalize Patient Care in Community-Acquired Bacterial Pneumonia (CABP)? Expires on Dec 14, 2021 CME 1.5 Community Practice Connections™ 17th Annual Meeting of the International Society of Gastrointestinal Oncology Expires on Dec 14, 2021 CME 2.0 Updates in the Journey for Disease-Modifying Therapies for Alzheimer Disease Expires on Dec 14, 2021 CME 1.25	15 Oncology Briefings™: A Nurses' Guide to Optimize Integration of CAR T Cell Therapy Expires on Dec 15, 2021 CME Advances In™ NSCLC: How Do Brain Metastases Impact Treatment Decision-Making Along Lines of Care? Expires on Dec 15, 2021 CME 1.0 The Role of Anticoagulants for Secondary Prevention in Patients With CAD and PAD: When Should Therapy Initiated? Expires on Dec 15, 2021 CME 1.5 Medical Crossfire®: How Can We Maximize Outcomes With PI3K Inhibitors Across Hematologic Malignancies? December 15, 2021 Live, Virtual Satellite Symposium CME 2.0	16 Medical Crossfire®: Bridging Unmet Needs With Emerging Data in Relapsed/Refractory DLBCL to Improve Patient Outcomes Expires on Dec 16, 2021 CME 3.0 Medical Crossfire®: Applying the Evidence in Acute Lymphoblastic Leukemia From Pediatric to Adult Case Scenarios December 16, 2021 Live Webcast CME 2.0 Managing the Whole Patient With Hemophilia A: Clinical Evidence and Practical Strategies December 16, 2021 Live Webcast CME 2.0 Virtual Tumor Board®: EGFR Mutation Matters: Optimizing Therapy by EGFR Mutation Subtype and Co-Mutations December 16, 2021 Live Webcast CME 1.5	17 Sickle Cell Disease: Targeting Complications to Improve Long-Term Implications Expires on Dec 17, 2021 CME 2.5 Understanding Cold Agglutinin Disease: How Do Emerging Treatment Options Have the Potential to Transform Patient Outcomes? Expires on Dec 17, 2021 CME 2.0	18 Oncology Briefings™: Identifying and Treating Patients with RET- Rearranged Non–Small Cell Lung Cancer Expires on Dec 18, 2021 CME 1.0 Community Practice Connections™: Medical Crossfire®: Are You Up to Date on Vaccinations? Incorporating Guideline-Based Care to Ensure Shingles Prevention in Your Patients Expires on Dec 18, 2021 CME 1.5 Individualizing Treatment Plans and Optimizing Outcomes for Patients With MF and PV: Stories Behind the Science Expires on Dec 18, 2021 CME 2.5 How to Do It™ Interactive Workshop: Taking Action With Clinical Advances in Chronic Lymphocytic Leukemia Expires on Dec 18, 2021 CME 3.0
19	20	21 Medical Crossfire®: Navigating Treatment Decisions in Advanced Prostate Cancer As New Options Emerge Expires on Dec 21, 2021 CME 1.5 Cancer Care in the COVID-19 Era: Assessing the Impact of Racial and Ethnic Disparities Expires on Dec 21, 2021 CME 1.50 T-Cell Lymphoma Tumor Board: Application of Novel Agents for the Treatment of PTCL and CTCL Expires on Dec 21, 2021 CME 3.0	22 Cancer Summaries and Commentaries™: Report from San Diego on Advancements in Acute Lymphocytic Leukemia Expires on Dec 22, 2021 CME 1.5 Clinical Consultations™: Streamlining the Pathway From Diagnosis to Treatment in Patients With MPS 1 Expires on Dec 22, 2021 CME 1.5	23 Cancer Summaries and Commentaries™: Report from San Diego on Advances in the Treatment of CLL Expires on Dec 23, 2021 CME 1.0 Cancer Summaries and Commentaries™: Updates from San Diego on the Treatment of GvHD Expires on Dec 23, 2021 CME 1.5 Oncology Briefings®: Highlighting New Multiple Myeloma Treatments for the Oncology Nurse Expires on Dec 23, 2021 CME Community Practice Connections™: Optimizing Outcomes in VTE Management: Collaborating Across the Continuum Expires on Dec 23, 2021 CME 1.50 Community Practice Connections™: Leveraging T-Cell Engaging Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia Expires on Dec 23, 2021 CME 1.5 Community Practice Connections™: Leveraging Novel Antibody-Drug Conjugates in a World of Evolving Treatment Paradigms: A Pan Tumor Perspective Expires on Dec 23, 2021 CME 1.5 Clinical Consultations™: Perspectives on Managing Retinal Diseases – Streamlining the Pathway from Diagnosis to Treatment Expires on Dec 23, 2021 CME 1.5 Strategies for Health Care Providers to Mitigate Cancer Care Disparities: A Multidisciplinary Panel Discussion Expires on Dec 23, 2021 CME 1.5	24	25
26	27	28	29	30	31 Hypoglycemia Prevention Starts in Primary Care: Evidence-Based Interventions for Mitigating Risk and Improving Patient Outcomes Expires on Dec 31, 2021 CME 1.5